|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$198,559,401 |
|
|
Indirect Value
|
$175,231,488 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-04-06 |
4 |
S |
$3.40 |
$288,575 |
D/D |
(85,000) |
3,633,779 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-05-07 |
4 |
B |
$3.12 |
$45,230 |
D/D |
14,515 |
3,648,294 |
2.37 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-05-25 |
4 |
B |
$1.94 |
$299,807 |
D/D |
126,215 |
3,774,509 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-05-27 |
4 |
B |
$2.06 |
$412,680 |
D/D |
200,000 |
3,974,509 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-05-28 |
4 |
B |
$2.05 |
$381,787 |
D/D |
186,684 |
4,161,193 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-06-01 |
4 |
B |
$2.03 |
$88,040 |
D/D |
43,316 |
4,204,509 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-06-02 |
4 |
B |
$2.10 |
$14,232 |
D/D |
6,779 |
4,211,288 |
2.37 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-06-03 |
4 |
B |
$2.55 |
$293,482 |
D/D |
115,290 |
4,326,578 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-06-04 |
4 |
B |
$2.68 |
$337,992 |
D/D |
126,286 |
4,452,864 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-06-07 |
4 |
B |
$2.56 |
$281,072 |
D/D |
110,000 |
4,562,864 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-11-01 |
4 |
B |
$2.80 |
$9,010,000 |
D/D |
3,217,857 |
7,780,721 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-11-08 |
4 |
B |
$4.00 |
$27,200 |
D/D |
6,800 |
7,787,521 |
2.37 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-11-29 |
4 |
S |
$2.76 |
$4,683,500 |
D/D |
(1,700,000) |
6,087,521 |
0 |
- |
|
TTHI |
Transition Therapeutics |
10% Owner |
|
2010-12-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
897,084 |
|
- |
|
TTHI |
Transition Therapeutics |
10% Owner |
|
2010-12-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,392,894 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-12-14 |
4 |
S |
$2.58 |
$55,470 |
I/I |
(21,500) |
21,500 |
0 |
- |
|
TTHI |
Transition Therapeutics |
10% Owner |
|
2011-11-22 |
4 |
B |
$1.35 |
$2,600,000 |
D/D |
1,925,926 |
2,823,010 |
2.45 |
- |
|
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2012-01-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,124,876 |
|
- |
|
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2012-01-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,966,419 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2012-03-02 |
4 |
B |
$3.33 |
$2,653,754 |
D/D |
796,923 |
6,954,144 |
2.45 |
- |
|
AWH |
Aspira Womens Health Inc |
10% Owner |
|
2013-05-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,617,872 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2013-08-20 |
4 |
B |
$1.45 |
$159,518 |
D/D |
110,005 |
7,064,149 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2013-08-21 |
4 |
B |
$1.40 |
$278,961 |
D/D |
199,586 |
7,263,735 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2013-08-22 |
4 |
B |
$1.36 |
$127,565 |
D/D |
93,777 |
7,357,512 |
2.45 |
- |
|
AWH |
Aspira Womens Health Inc |
10% Owner |
|
2013-12-19 |
4 |
OE |
$1.46 |
$5,920,529 |
D/D |
4,055,157 |
6,673,029 |
0 |
- |
|
634 Records found
|
|
Page 6 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|